History

1992
- Foundation of Medical Strategy GmbH by Dr. Michael Fischer
1998
- Permission to operate financial portfolio management by the German Federal Banking Supervisory Office (BaKred, now BaFin)
- Takeover of the first fund mandate
2000
- Initiation and launch of MEDICAL BioHealth, start of partnership with Oppenheim Asset Management in Luxembourg.
- Harald Schwarz and Jürgen Harter join Medical Strategy
2001
- Fund of the Year" awarded for the first time by FINANZEN magazine

2004
- MEDICAL BioHealth receives AA rating from Standard & Poor's for the first time
- Dr. Michael Fischer receives three gold medals for the first time from Sauren Fonds Research
2005
- Initiation and launch of apo Medical Opportunities, fund management for approx. 50% of the fund volume. Start of partnership with apo asset, a subsidiary of Deutsche Apotheker- und Ärztebank.
2006
- Awarding of the Lipper Fund Award for MEDICAL BioHealth
2009
- Awarding of the Sauren Golden Award to Dr. Michael Fischer
2010
- First award of the Long-Term Fund Management Rating (5 year) by Standard & Poor's for MEDICAL BioHealth
- 10th anniversary of MEDICAL BioHealth
2011
- First award of Gold Fund Grading and 5-year Long-Term Grading by S&P Capital IQ for MEDICAL BioHealth
2014
- Launch of apo Medical Opportunities Institutional, fund management for approx. 50% of the fund volume

2017
- Investment Advisory (as of 01.09.17 Fund Management) of RIM GLOBAL BIOSCIENCE.
- Mario Linimeier is appointed Managing Director
2018
- Medical Strategy is awarded the FinanzResearch AWARD. In the field of independent asset managers in Germany, the company was rated "Outstanding".
- At the "Funds Europe Awards" in London, Medical Strategy is awarded a special recommendation in the category "European Specialized Investment Company of the Year".
2019
- Apo Asset Management (apoAsset) acquires a stake in Medical Strategy.
2020
- Medical Strategy receives seven Euro Fund Awards for MEDICAL BioHealth and RIM Global Bioscience
- Katrin Winterstein appointed authorized signatory
2021
- Medical Strategy receives nine Euro Fund Awards for MEDICAL BioHealth and RIM Global Bioscience

Skip Links